<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="154850">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT02085291</url>
  </required_header>
  <id_info>
    <org_study_id>2011ZDllKY03.1</org_study_id>
    <secondary_id>targeting microcirculation</secondary_id>
    <nct_id>NCT02085291</nct_id>
  </id_info>
  <brief_title>Targeting the Microcirculation in Resuscitation of Patients With Septic Shock</brief_title>
  <sponsors>
    <lead_sponsor>
      <agency>Southeast University, China</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Southeast University, China</source>
  <oversight_info>
    <authority>China:Hospital Ethics Committee</authority>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Increase in MAP from 65 mm Hg to patients' usual level by fluid improved sublingual
      microcirculation in early septic shock patients despite EGDT.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>September 2011</start_date>
  <completion_date type="Anticipated">December 2014</completion_date>
  <primary_completion_date type="Anticipated">December 2014</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Factorial Assignment, Masking: Open Label, Primary Purpose: Treatment</study_design>
  <primary_outcome>
    <measure>Sublingual microcirculatory function by SDF of all the patients</measure>
    <time_frame>20minutes</time_frame>
    <safety_issue>No</safety_issue>
  </primary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">20</enrollment>
  <condition>Septic Shock</condition>
  <arm_group>
    <arm_group_label>Resp-FL</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Fluid positive for PLR, then saline performed until MAP to usual level</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Resp-NE</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Fluid responders confirmed by PLR, then NE was adjusted to titrate MAP to usual level</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Nonres-NE</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Fluid nonresponders confirmed by PLR, then NE was adjusted to titrate MAP to usual level.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>NE</intervention_name>
    <description>NE infusion to titrate MAP to usual level</description>
    <arm_group_label>Resp-NE</arm_group_label>
    <arm_group_label>Nonres-NE</arm_group_label>
    <other_name>NE infusion</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Saline</intervention_name>
    <description>Fluid resuscitation to titrate MAP to usual level</description>
    <arm_group_label>Resp-FL</arm_group_label>
    <other_name>Fluid resuscitation</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  1) patients with septic shock for less than 24 hours.

          -  2) Fluid resuscitation was performed according to the guideline for treating septic
             shock to maintain the central venous pressure (CVP) for more than 8 mm Hg and central
             venous oxygen saturation for more than 70%.

          -  3) Patients requiring norepinephrine (NE) to maintain a MAP of 65 mm Hg.

        Exclusion Criteria:

          -  pregnancy, age &lt; 18 years, inability to acquire the usual level of MAP, refusal of
             consent by the patient or relative, participation in other trials during the last
             three months, hypertensive patients without hypertension treatment.
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>90 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Jingyuan Xu, M.D.</last_name>
    <phone>0086-025-83262550</phone>
    <email>xujingyuanmail@163.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Zhongda Hospital Southeast University</name>
      <address>
        <city>Nanjing</city>
        <state>Jiangsu</state>
        <zip>210000</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jingyuan Xu, MD</last_name>
      <phone>862586232550</phone>
    </contact>
    <investigator>
      <last_name>Jingyuan Xu, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>March 2014</verification_date>
  <lastchanged_date>March 10, 2014</lastchanged_date>
  <firstreceived_date>February 28, 2014</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Southeast University, China</investigator_affiliation>
    <investigator_full_name>Jingyuan,Xu</investigator_full_name>
    <investigator_title>Zhongda Hospital</investigator_title>
  </responsible_party>
  <keyword>septic shock, microcirculation, fluid</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Shock</mesh_term>
    <mesh_term>Shock, Septic</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
